Organization: Cumming School of Medicine

Tune in, turn on, and lead in psychedelic-assisted therapy

Canada can be a leader in delivering widespread, well-regulated psychedelic-assisted therapy for people with depression, anxiety, post-traumatic stress disorder and substance abuse, by investing in research, educating health care professionals and providing the necessary clinical infrastructure, Dr. Ross Marshall, chief scientific officer at The Newly Institute based in Calgary, says in an op-ed.

The Short Report, March 25, 2020: Tech CEOs implore Ottawa to protect their industry, the NGEN supercluster commits $50M to scaling up production of supplies to fight COVID-19, and more

The Canadian Institutes of Health Research launched a new COVID-19 funding opportunity for operating grants called the “COVID-19 Clinical Epidemiology Research Rapid Response.” The application deadline is this Friday, March 27, and successful applicants will be notified of the decision on April 1. The competition description emphasizes the viruses “many unknown epidemiological parameters, particularly with respect…